UV immunosuppression and cutaneous malignancies

References

• Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case-control study within the Nurses’ Health Study. Int. J. Epidemiol.35(6), 1514–1521 (2006).
   PubMed Web of Science ®Google Scholar
• Jerant AF, Johnson JT, Sheridan CD. Early detection and treatment of skin cancer. Am. Fam. Physician62(2), 357–368, 375–376, 381–382 (2000).
   PubMed Web of Science ®Google Scholar
• Wang SQ, Balagula Y, Osterwalder U. Photoprotection: a review of the current and future technologies. Dermatol. Ther.23(1), 31–47 (2010).
   PubMed Web of Science ®Google Scholar
• MacKie RM, Hauschild A, Eggermont AMM. Epidemiology of cutaneous melanoma. Ann. Oncol.20(Suppl. 6), vi1–vi7 (2009).
   PubMed Web of Science ®Google Scholar
• Young A, Wikonkái NM. The chronic effects of ultraviolet radiation on the skin: photocarcinogenesis. In: Photodermatology. Lim HW, Hönigsmann H, Hawk JLM (Eds). Informa Healthcare USA, NY, USA, 107–117 (2007).
   Google Scholar
• Wang Y, DiGiovanna JJ, Stern JB et al. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc. Natl Acad. Sci. USA106(15), 6279–6284 (2009)
   PubMedGoogle Scholar
• Burnet M. Concepts of autoimmune disease and their implication for therapy. Perspect. Biol. Med.10(2), 141–151 (1967).
   PubMedGoogle Scholar
• Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity21(2), 134–148 (2004).
   PubMedGoogle Scholar
• Baron ED. The immune system and nonmelanoma skin cancers. In: Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas. Reichrath J (Ed.). Landes Biosciences, TX, USA, 43–48 (2006).
   Google Scholar
• Jemec GB, Holm EA. Nonmelanoma skin cancer in organ transplant patients. Transplantation75(3), 253–257 (2003).
   PubMedGoogle Scholar
• Veness MJ. Defining patients with high-risk cutaneous squamous cell carcinoma. Australas. J. Dermatol.47(1), 28–33 (2006).
   PubMedGoogle Scholar
• Le Mire L, Hollywood K, Gray D et al. Melanomas in renal transplant recipients. Br. J. Dermatol.154(3), 472–477 (2006).
   PubMed Web of Science ®Google Scholar
• Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J. Am. Acad. Deramatol.40(2), 177–186 (1999).
   PubMed Web of Science ®Google Scholar
• Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology44(16), 1172–1181 (1997).
   PubMedGoogle Scholar
• Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression on kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet351(9103), 623–628 (1998).
   PubMed Web of Science ®Google Scholar
• Wilkins K, Turner R, Dolev JC et al. Cutaneous malignancy and human immunodeficiency virus disease. J. Am. Acad. Dermatol.54(2), 189–206 (2006).
   PubMedGoogle Scholar
• Nguyen P, Vin-Christian K, Ming ME et al. Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch. Dermatol.138(6), 758–763 (2002).
   PubMedGoogle Scholar
• Pardoll D. Does the immune system see tumors as foreign or self? Annu. Rev. Immunol.21, 807–839 (2003).
   PubMed Web of Science ®Google Scholar
• Santo Domingo D, Baron ED. Melanoma and nonmelanoma skin cancers and the immune system. In: Sunlight, Vitamin D and Skin Cancer. Reichrath J (Ed.). Landes Bioscience, TX, USA, 187–202 (2008).
   Google Scholar
• Farnoush A, Mackenzie IC. Sequential histological changes and mast cell response in skin during chemically-induced carcinogenesis. J. Oral Pathol.12(4), 300–306 (1983).
   PubMedGoogle Scholar
• Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem. Biol.3(11), 895–904 (1996).
   PubMed Web of Science ®Google Scholar
• Coussens LM, Tinkle CL, Hanahan D et al. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell103(3), 481–490 (2000).
   PubMed Web of Science ®Google Scholar
• Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol.170(2), 774–786 (2007).
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Sherry RM, Morton KE et al. Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J. Immunol.175(9), 6169–6176 (2005).
   PubMed Web of Science ®Google Scholar
• Pardoll DM, Topalian SL. The role of CD4+ T-cell responses in antitumor immunity. Curr. Opin. Immunol.10(5), 588–594 (1998).
   PubMed Web of Science ®Google Scholar
• Nagai H, Horikawa T, Hara I et al. In vivo elimination of CD25+ regulatory T-cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer. Exp. Dermatol.13(10), 613–620 (2004).
   PubMed Web of Science ®Google Scholar
• Turk MJ, Guevara-Patino JA, Rizzuto GA et al. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T-cells. Exp. Med.200(6), 771–782 (2004).
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Godfrey DI, Tapani JA. A fresh look at immunosurveillance and immunotherapy. Nat. Immunol.2(4), 293–299 (2001).
   PubMed Web of Science ®Google Scholar
• Merad M, Ginhoux F, Collin M. Origin, homeostasis, and function of langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol.8(12), 935–947 (2008).
   PubMed Web of Science ®Google Scholar
• Schwarz T, Halliday GM. Photoimmunology. In: Photodermatology. Lim HW, Hönigsmann H, Hawk JLM (Eds). Informa Healthcare USA, NY, USA, 55–74 (2007).
   Google Scholar
• Hanneman KK, Cooper KD, Baron ED. Ultraviolet immunosuppression: mechanisms and consequences. Dermatol. Clin.24, 19–25 (2006).
   PubMedGoogle Scholar
• Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol.124(1), 445–453 (1980).
   PubMed Web of Science ®Google Scholar
• Aberer W, Schuler G, Stingl G et al. Ultraviolet light depletes surface markers of Langerhans cells. J. Invest. Dermatol.76(3), 202–210 (1981).
   PubMed Web of Science ®Google Scholar
• Noonan FP, De Fabo EC, Kripke ML. Suppression of contact hypersensitivity by ultraviolet radiation: an experimental model. Springer Semin. Immunopathol.4(3), 293–304 (1981).
   PubMed Web of Science ®Google Scholar
• Morrison WL, Bucana C, Kripke ML. Systemic suppression of contact hypersensitivity by UVB radiation is unrelated to UVB-induced alterations in the morphology and number of Langerhans cells. Immunology52(2), 299–306 (1984).
   PubMedGoogle Scholar
• Schwarz T, Urbanska A, Gschnait F, Luger TA. Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine. J. Invest. Dermatol.87(2), 289–291 (1986).
   PubMed Web of Science ®Google Scholar
• Cooper KD, Oberhelman L, Hamilton TA et al. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc. Natl Acad. Sci. USA89(18), 8497–8501 (1992).
   PubMed Web of Science ®Google Scholar
• Bennett CL, van Rijn E, Steffen J et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol.169(4), 569–576 (2005),
   PubMed Web of Science ®Google Scholar
• Kissenpfennig A, Henri S, Dubois B et al. Dynamics and functions of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity22(5), 643–654 (2005).
   PubMed Web of Science ®Google Scholar
• Kaplan DH, Jenison MC, Saeland S et al. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity23(6), 611–620 (2005).
   PubMed Web of Science ®Google Scholar
• Hammerberg C, Duraiswamy N, Cooper KD. Temporal correlation between UV radiation locally-inducible tolerance and the sequential appearance of dermal, then epidermal, class II MHC+CD11b+ monocytic/macrophagic cells J. Invest. Dermatol.107(5), 755–763 (1996).
   PubMedGoogle Scholar
• Yoshida Y, Kang K, Berger M et al. Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J. Immunol.161(11) 5873–5879 (1998).
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Kang K, Chen G et al. Cellular fibronectin is induced in ultraviolet-exposed human skin and induces IL-10 production by monocytes/macrophages. J. Invest. Dermatol.113(1), 49–55 (1999).
   PubMedGoogle Scholar
• Takahara M, Kang K, Liu Liming et al. iC3b arrests monocytic cell differentiation into CD1c-expressing dendritic cell precursors: a mechanism for transiently decreased dendritic cells in vivo after human skin injury by ultraviolet B. J. Invest. Dermatol.120(5), 802–809 (2003).
   PubMedGoogle Scholar
• Toichi E, Lu KQ, Swick AR, McCormick TS et al. Skin-infiltrating monocytes/macrophages migrate to draining lymph nodes and produce IL-10 after contact sensitizer exposure to UV-irradiated skin. J. Invest. Dermatol.128(11), 2705–2715 (2008).
   PubMed Web of Science ®Google Scholar
• Ritter U, Meißner A, Scheidig C et al. CD8α- and langerin-negative dendritic cells but not Langerhans cells, act as principle antigen-presenting cells in leishmaniasis. Eur. J. Immunol.34(6), 1542–1550 (2004).
   PubMed Web of Science ®Google Scholar
• Fukunaga A, Khaskhely NM, Sreevidya CS et al. Dermal dendritic cells, no Langerhans cells, play an essential role in inducing an immune response. J. Immunol.180(5), 3057–3064 (2008)
   PubMedGoogle Scholar
• Poulin LF, Henri S, de Bovis B et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med.204(13), 3119–3131 (2007).
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Collin MP, Bogunovic M et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med.204(13), 3133–3146 (2007).
   PubMed Web of Science ®Google Scholar
• Bursch LS, Wang L, Igyarto B et al. Identification of a novel population of langerin+ dendritic cells. J. Exp. Med.204(13), 3147–3156 (2007).
   PubMed Web of Science ®Google Scholar
• Bobr A, Olvera-Gomez I, Igyarto BZ et al. Acute ablation of langerhans cells enhances skin immune responses. J. Immunol.185(8), 4724–4728 (2010).
   PubMedGoogle Scholar
• Fukunaga A, Khaskhely NM, Ma Y et al. Langerhans cells serve as immunoregulatory cells by activating NKT cells. J. Immunol.185(8), 4633–4640 (2010).
   PubMedGoogle Scholar
• Yoshiki R, Kabashima K, Sakabe J et al. The mandatory role of IL-10 producing OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression. J. Immunol.184(10), 5670–5677 (2010).
   PubMedGoogle Scholar
• Schwartz T. Mechanisms of UV-induced immunosuppression. Keio J. Med.54(4), 165–171 (2005).
   PubMedGoogle Scholar
• Schwarz A, Noordegraaf M, Maeda A et al. Langerhans cells are required for UVR-induced immunosuppression. J. Invest. Dermatol.130(5), 1419–1427 (2010).
   PubMed Web of Science ®Google Scholar
• Green EA, Choi Y, Flavell RA. Pancreatic lymph node-derived CD4+ 25+ Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity16(2), 183–191 (2002).
   PubMed Web of Science ®Google Scholar
• Loser K, Mehling A, Loeser S et al. Epidermal RANKL controls regulatory T cell numbers via activation of dendritic cells. Nat. Med.12(12), 1372–1379 (2006).
   PubMed Web of Science ®Google Scholar
• Norman AW. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am. J. Clin. Nutr.67(6), 1108–1110 (1998).
   PubMed Web of Science ®Google Scholar
• Schwarz T. 25 Years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to the highly respected regulatory T cells. Photochem. Photobiol.84(1), 10–18 (2008).
   PubMed Web of Science ®Google Scholar
• Schwarz A, Beissert S, Grosse-Heitmeyer K. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J. Immunol.165(4), 1824–1831 (2000).
   PubMed Web of Science ®Google Scholar
• Ghoreishi M, Dutz JP. Tolerance induction by transcutaneous immunization through ultraviolet-irridated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J. Immunol.176(4), 2635–2644 (2006).
   PubMed Web of Science ®Google Scholar
• Gorman S, Tan JWY, Yerkovich ST et al. CD4+ T cells in lymph nodes of UVB-irradiated mice suppress immune responses to new antigens both in vitro and in vivo. J. Invest. Dermatol.127(4), 915–924 (2007).
   PubMedGoogle Scholar
• Rana S, Byrne SN, MacDonald LJ. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am. J. Pathol.24(1), 127–137 (2010).
   Google Scholar
• Balato A, Ununtmaz D, Gaspari AA. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J. Invest. Dermatol.129(7), 1628–1642 (2009).
   PubMed Web of Science ®Google Scholar
• Crowe NY, Croquet JM, Berzins SP et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med.202(9), 1279–1288 (2005).
   PubMed Web of Science ®Google Scholar
• Terabe M, Swann J, Ambrosino E et al. A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med.202(12), 1627–1633 (2005).
   PubMed Web of Science ®Google Scholar
• Moodycliffe AM, Nghiem D, Clydesdale G et al. Immunosuppression and skin cancer development: regulation by NKT cells. Nat. Immunol.1(6), 521–525 (2000).
   PubMed Web of Science ®Google Scholar
• Girardi M, Oppenheim DE, Steele CR et al. Regulation of cutaneous malignancy by γδ T cells. Science294(5542), 605–609 (2001).
   PubMed Web of Science ®Google Scholar
• Pardoll DM. Immunology. Stress, NK receptors and immune surveillance. Science294(5542), 534–536 (2004).
   Google Scholar
• Kim J, Modlin RL, Moy RL et al. IL-10 production in cutaneous basal and squamous cell carcinomas. a mechanism for evading the local T cell immune response. J. Immunol.155(4), 2240–2247 (1995).
   PubMed Web of Science ®Google Scholar
• Rivas JM, Ullrich SE. Systemic suppression of DTH by supernatants from UV-irradiated keratinocytes: an essential role for interleukin-10. J. Immunol.149(12), 3865–3871 (1992).
   PubMed Web of Science ®Google Scholar
• Enk AH, Saloga J, Becker D et al. Induction of hapten-specific tolerance by interleukin-10 in vivo. J. Exp. Med.179(4), 1397–1402 (1994).
   PubMed Web of Science ®Google Scholar
• Loser K, Apelt J, Voskort M. IL-10 controls ultraviolet-induced carcinogenesis in mice. J. Immunol.179(1), 165–171 (2007).
   Google Scholar
• Li-Weber M, Krammer PH. Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat. Rev. Immunol.3(7), 534–543 (2003).
   PubMed Web of Science ®Google Scholar
• Moore RJ, Owens DM, Stamp G et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med.5(7), 828–831 (1999).
   PubMed Web of Science ®Google Scholar
• Schmitt DA, Owen-Schaub L, Ullrich SE. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J. Immunol.154(10), 5114–5120 (1995).
   PubMed Web of Science ®Google Scholar
• Schmitt DA, Walterscheid JP, Ullrich SE. Reversal of ultraviolet radiation induced immunosuppression by recombinant interleukin-12: suppression of cytokine production. Immunology101(1), 90–96 (2000).
   PubMedGoogle Scholar
• Schwartz A, Stander S, Berneburg M et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. J. Exp. Med.4(1), 26–31 (2002).
   Google Scholar
• Schwarz A, Maeda A, Kernebeck K et al. Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J. Exp. Med.201(2), 173–179 (2005).
   PubMed Web of Science ®Google Scholar
• Walters IB, Ozawa M, Cardinale I et al. Narrowband (312-nm) UV-B suppresses interferon γ and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch. Dermatol.139(2), 155–161 (2003).
   PubMed Web of Science ®Google Scholar
• Schwarz A, Maeda A, Ständer S et al. IL-18 reduces ultraviolet radiation-induced DNA damage and thereby immunosuppression. J. Immunol.176(5), 2896–2901 (2010).
   Google Scholar
• Aoki M, Pawankar R, Niimi Y et al. Mast cells in basal cell carcinoma express VEGF, IL-8, and RANTES. Int. Arch. Allergy Immunol.130(3), 216–223 (2003).
   PubMedGoogle Scholar
• Aoki M, Pawankar R, Niimi Y et al. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α. J. Immunol.167(7), 4008–4016 (2001).
   PubMedGoogle Scholar
• Hart PH, Grimbaldeston MA, Swift GJ et al. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J. Exp. Med.187(12), 2045–2053 (1998).
   PubMed Web of Science ®Google Scholar
• Byrne SN, Limón-Flores AY, Ullrich SE. Mast cells migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J. Immunol.180(7), 4648–4655 (2007).
   Google Scholar
• Yarosh DB. DNA repair, immunosuppression, and skin cancer. Cutis74(Suppl. 5), 10–13 (2004).
   PubMed Web of Science ®Google Scholar
• Proietti De Santis L, Garcia CL, Balajee AS et al. Transcription coupled repair efficiency determines the cell cycle progression and apoptosis after UV exposure in hamster cells. DNA Repair (AMST)1(3), 209–223 (2002).
   PubMed Web of Science ®Google Scholar
• Costa RM, Chiganças V, Galhardo Rda S, Carvalho H, Menck CF. The eukaryotic nucleotide excision repair pathway. Biochimie85(11), 1083–1099 (2003).
   PubMed Web of Science ®Google Scholar
• Ford JM. Regulation of DNA damage recognition and nucleotide excision repair: another role for p53. Mutat. Res.577(1–2), 195–202 (2005).
   PubMed Web of Science ®Google Scholar
• Besaratinia A, Synold TW, Chen HH et al. DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc. Natl Acad. Sci. USA102(29), 10058–10063 (2005).
   PubMed Web of Science ®Google Scholar
• Batista LF, Kaina B, Meneghini R et al. How DNA lesions are turned into powerful killing structures: insights from UV-induced apoptosis. Mutat. Res.681(2–3), 197–208 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu RS, Fu W et al. Production of reactive oxygen species and 8-hydroxyl-2´deoxyguanosine in KB cells co-exposed to benzo[a]pyrene and UV-A radiation. Chemosphere55(10), 1303–1308 (2004).
   PubMed Web of Science ®Google Scholar
• Javeri A, Huang XX, Bernerd F et al. Human 8-oxoguanine-DNA glycosylase 1 protein and gene are expressed more abundantly in the superficial than basal layer of human epidermis. DNA Repair7(9), 1542–1550 (2008).
   PubMedGoogle Scholar
• Cooper KD. Cell-mediated immunosuppressive mechanisms induced by UV radiation. Photochem. Photobiol.63(4), 400–406 (1996).
   PubMedGoogle Scholar
• Barresi C, Stremnitzer C, Mlitz V et al. Increased sensitivity of histidiniemic mice to UVB radiation suggests a crucial role of endogenous urocanic acid in photoprotection. J. Invest. Dermatol.131(1), 188–194 (2011).
   PubMed Web of Science ®Google Scholar
• Kammeyer A, Eggelte TA, Overmars H et al. Oxidative breakdown and conversion of urocanic acid isomers by hydroxyl radical generating systems. Biochem. Biophys. Acta1526(2), 277–285 (2001).
   PubMed Web of Science ®Google Scholar
• Kurimoto I, Streilein JW. cis urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-α. J. Immunol.148(10), 3072–3078 (1992).
   PubMed Web of Science ®Google Scholar
• Beissert ST, Mohammad H, Torri A et al. Regulation of tumor antigen presentation by urocanic acid. J. Immunol.159(1), 92–96 (1997).
   PubMedGoogle Scholar
• Gruner SW, Diezel H, Stoppe H et al. Inhibition of skin allograft rejection and acute graft-versus-host disease by cis-urocanic acid. J. Invest. Dermatol.98(4), 459–462 (1992).
   PubMedGoogle Scholar
• Filipec ME, Letko Z, Haskova D et al. The effect of urocanic acid on graft rejection in an experimental model of orthotopic corneal transplantation in rabbits. Graefes Arch. Clin. Exp. Ophthalmol.236(1), 65–68 (1998).
   PubMedGoogle Scholar
• Kaneko K, Smetana-Just U, Matsui M et al.cis-urocanic acid initiates gene transcription in primary human keratinocytes. J. Immunol.181(1), 217–224 (2008).
   PubMedGoogle Scholar
• Halliday GM. Common links among the pathways leading to UV-induced immunosuppression. J. Invest. Dermatol.130(5), 1209–1212 (2010).
   PubMed Web of Science ®Google Scholar
• Sreevidya CS, Fukunaga A, Khaskhely NM et al. Agents that reverse UV-induced immune suppression and photocarcinogenesis affect DNA repair. J. Invest. Dermatol.130(5), 1428–1437 (2010).
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Challa A, McCormick TS, Cooper KD, Mukhtar H. Prevention of UVB-induced immunosuppression in mice by green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis20(11), 2117–2124 (1999).
   PubMed Web of Science ®Google Scholar
• Kuchel JM, Barnetson RSC, Zhuang L et al. Tamarind inhibits solar-simulated ultraviolet radiation-induced suppression of recall responses in humans. Lett. Drug Design Discov.2(2), 165–171 (2005).
   Google Scholar
• Camouse MM, Domingo DS, Swain FR et al. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Exp. Dermatol.18(6), 522–526 (2009).
   PubMed Web of Science ®Google Scholar
• Yamaguchi LF, Kato MJ, Di Mascio P. et al. Biflavonoids from Araucaria angustifolia protects against UV-induced damage. Phytochemistry70(5), 615–620 (2009).
   PubMed Web of Science ®Google Scholar
• Afaq F, Zaid MA, Khan N et al. Protective effect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin. Exp. Dermatol.18(6), 553–561 (2009).
   PubMed Web of Science ®Google Scholar
• Matthews YJ, Halliday GM, Phan TA, Damian DL. A UVB wavelength dependency for local suppression of recall immunity in humans demonstrates a peak at 300nm. J. Invest. Dermatol.130(6), 1680–1684 (2010).
   PubMedGoogle Scholar
• Freeman SE, Hacham H, Grange RW et al. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc. Natl Acad. Sci. USA86(14), 5605–5609 (1989).
   PubMed Web of Science ®Google Scholar
• McLoone P, Simics E, Barton A et al. An action spectrum for the production of cis-urocanic acid in human skin in vivo. J. Invest. Dermatol.124(5), 1071–1074 (2005).
   PubMedGoogle Scholar
• Matthews YJ, Halliday GM, Phan TA, Damian DL. Wavelength dependency for UVA-induced suppression of recall immunity in humans. J. Dermatol. Sci. DOI: 10.1016/j.jdermsci.2010.07.005 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Furio L, Berthier-Vergnes O, Ducarre B et al. UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells. J. Invest. Dermatol.125(5), 1032–1038 (2005).
   PubMedGoogle Scholar
• Walterscheid JP, Ullrich SE, Nghiem DX. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med.195(2), 171–179 (2002).
   PubMed Web of Science ®Google Scholar
• Shreedhar V, Giese T, Sung VW et al. A cytokine cascade including prostaglandin E-2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol.160(8), 3783–3789 (1998).
   PubMed Web of Science ®Google Scholar
• Sasaki M, Yamaoka J, Miyachi Y. The effect of ultraviolet B irradiation on nitric oxide synthase expression in murine keratinocytes. Exp. Dermatol.9(6), 417–422 (2000).
   PubMedGoogle Scholar
• Warren JB, Loi RK, Coughlan ML. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. Br. J. Pharmacol.109(3), 802–806 (1993).
   PubMedGoogle Scholar
• Zingarelli B, O’Connor M, Wong H et al. Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol.156(1), 350–358 (1996).
   PubMed Web of Science ®Google Scholar
• Yuen KS, Nearn MR, Halliday GM. Nitric oxide-mediated depletion of Langerhans cells from the epidermis may be involved in UVA radiation-induced immunosuppression. Nitric Oxide6(3), 313–318 (2002).
   PubMedGoogle Scholar
• Russo PAJ, Halliday GM. Inhibition of nitric oxide and reactive oxygen species production improves the ability of a sunscreen to protect from sunburn, immunosuppression and photocarcinogenesis. Br. J. Dermatol.155(2), 408–415 (2006).
   PubMedGoogle Scholar
• Sano S, Chan KS, Kira M et al. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res.65(13), 5720–5729 (2005).
   PubMed Web of Science ®Google Scholar
• Sumita N, Bito T, Nakajima K, Nishigori C. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Exp. Dermatol.15(4), 291–299 (2006).
   PubMedGoogle Scholar
• Bito T, Sumita N, Masaki T et al. Ultraviolet light induces Stat3 activation in human keratinocytes and fibroblasts through reactive oxygen species and DNA damage. Exp. Dermatol.19(7), 654–660 (2010).
   PubMedGoogle Scholar
• Baron ED, Fourtanier A, Compan D et al. High ultraviolet A protection affords greater immune protection confirming that ultraviolet A contributes to photoimmunosuppression in humans. J. Invest. Dermatol.121(4), 869–875 (2003).
   PubMedGoogle Scholar
• Ke MS, Camouse MM, Swain FR et al. UV protective effects of DNA repair enzymes and RNA lotion. Photochem. Photobiol.84(1), 180–184 (2008).
   PubMed Web of Science ®Google Scholar